Incyte (MEX:INCY) Common Stock: MXN4 Mil (As of Mar. 2026)


MEX:INCY Incyte Corp MEX:INCY
82 GF Score
Price MXN2,064.54
GF Value MXN1,752.51
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Incyte Common Stock?

Incyte MEX:INCY +23.18% 82 Common Stock is MXN4 Mil as of Mar. 2026. GuruFocus rates MEX:INCY with a GF Score™ of 82/100 and a GF Value™ of MXN1,752.51 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Incyte's quarterly common stock declined from Sep. 2025 (MXN4 Mil) to Dec. 2025 (MXN4 Mil) but then increased from Dec. 2025 (MXN4 Mil) to Mar. 2026 (MXN4 Mil).

Incyte's annual common stock increased from Dec. 2023 (MXN4 Mil) to Dec. 2024 (MXN4 Mil) but then declined from Dec. 2024 (MXN4 Mil) to Dec. 2025 (MXN4 Mil).

Incyte Common Stock Historical Data

* Premium members only.

The historical data trend for Incyte's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incyte Common Stock Chart

Incyte Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.53 4.35 3.80 4.03 3.57

Incyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 3.65 3.60 3.57 3.61
MEX:INCY
82GF Score
Incyte Corp MEX:INCY
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Incyte Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN4 Mil mean?
Incyte (MEX:INCY) has a Common Stock of MXN4 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Incyte and its competitors.
Is Incyte's Common Stock too high?
Incyte's current Common Stock is MXN4 Mil. Overall, Incyte has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Incyte's Common Stock compare to INSM and BNTX?
Incyte's Common Stock of MXN4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Incyte and its competitors. Incyte's current Common Stock is MXN4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incyte stock overvalued right now?
Based on GuruFocus' analysis, Incyte (MEX:INCY) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN1,752.51, compared to a current price of MXN2,064.54 — trading 17.8% above its estimated fair value. The current Common Stock is MXN4 Mil. Incyte's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Incyte (MEX:INCY), the current Common Stock is MXN4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Incyte (MEX:INCY) Overvalued in 2026?

Based on GuruFocus' analysis, Incyte stock appears to be overvalued. The current stock price of MXN2,064.54 is trading 17.8% above its estimated GF Value™ of MXN1,752.51. GuruFocus considers Incyte to be Modestly Overvalued.

Key valuation signals for MEX:INCY:

  • Common Stock: MXN4 Mil
  • GF Value™: MXN1,752.51 vs. price of MXN2,064.54 (17.8% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the MEX:INCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Incyte Business Description

Address 1801 Augustine Cut-Off, Wilmington, DE, USA, 19803
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
82GF Score

Get the complete analysis for MEX:INCY

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,064.54
Price
MXN1,752.51
GF Value